Copyright © BusinessAMBE 2023
The pharmaceutical company
In the news:
The details:
- The new cancer vaccine is designed to train patients' immune systems to recognize and attack specific mutations in cancer cells.
- Previous studies already showed promise for the new vaccine in treating melanomas.
-
Now it has been shown that the vaccine could also work in other cancers.
Moderna reveals to Reuters that their vaccine provides a strong benefit and increases the chances of extending life. That is the conclusion of a trial of 22 patients who were given the mRNA-4157 vaccine in combination with the existing drug Pembrolizumab, better known by its brand name Keytruda. - This combination not only proved to be safe and well tolerated in the patients, it also showed positive activation of the immune response.
Stock price: Immediately after the results of the study were announced,
© The Content Exchange, source